Study S002094

Effect of GLPIR Stimulation on Neuroprotection and Inflammation in Parkinson's Disease

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03659682
Acronym: GIPD
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: QUADRUPLE
Status: UNKNOWN
Enrollment: 120
Start: 2019-01-02
Primary completion: 2024-12-31
Lead sponsor: Oslo University Hospital
Conditions: Parkinson Disease
Interventions: DRUG:Semaglutide
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Motor Function [48 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.